HS

Harout Semerjian

President & CEO

GlycoMimetics

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
GlycoMimetics
Industry
pharmaceuticals
Employees
21.0
Seniority
C suite
Annual Revenue
10000.0

Technologies

DNS Made Easy Outlook Microsoft Office 365 Google Analytics reCAPTCHA WordPress.org New Relic Google Font API YouTube Google Tag Manager Gravity Forms Mobile Friendly Remote

Keywords

small molecule drugs carbohydrate chemistry orphan drugs biotechnology healthcare life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing glycobiology oncology acute myeloid leukemia aml e-selectin antagonist uproleselan clinical trials biopharmaceuticals drug development glycomimetics sickle cell disease drug pipeline investigational drugs carbohydrate recognition breakthrough therapy fast track designation fda approval therapeutic innovation patient outcomes cancer treatments inflammatory diseases research partnerships drug commercialization proprietary chemistry clinical research scientific publications intellectual property biotech collaboration patient care therapeutic candidates pharmaceutical partnerships clinical efficacy treatment strategy research funding disease states translational research hematologic diseases drug design & development healthcare solutions clinical data investor relations corporate governance management team biomedical research drug discovery patient advocacy healthcare innovation health wellness & fitness hospital & health care pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans